Literature DB >> 3015749

Latent pulmonary involvement in Crohn's disease: biological, functional, bronchoalveolar lavage and scintigraphic studies.

P Bonniere, B Wallaert, A Cortot, X Marchandise, Y Riou, A B Tonnel, J F Colombel, C Voisin, J C Paris.   

Abstract

We have investigated the following pulmonary related parameters in 22 patients with Crohn's disease who were free of clinical pulmonary symptoms and had normal chest roentgenograms and in 25 controls: serum angiotensin converting enzyme, pulmonary function tests, bronchoalveolar lavage (lymphocyte count and subpopulations, macrophage viability and superoxide anion release by macrophages) and pulmonary scannings. Serum angiotensin converting enzyme was lower in Crohn's disease (14.1 +/- 5.1) than in controls (25.2 +/- 4.7) (p less than 0.001). Twelve of 22 Crohn's disease (54%) had a bronchoalveolar lavage lymphocytosis (greater than 18% alveolar lymphocytes). Bronchoalveolar lavage lymphocytes subpopulations were quite variable. Twelve of 17 Crohn's disease (71%) had an increase spontaneous and/or stimulated superoxide anion production by alveolar macrophages. Six of 12 Crohn's disease (50%) had an increase physiologic dead space in the upper part of their lung against one of 11 controls (9%). These data suggest that most patients with Crohn's disease have a latent pulmonary involvement.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3015749      PMCID: PMC1433358          DOI: 10.1136/gut.27.8.919

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  33 in total

1.  Pulmonary vasculitis and ulcerative colitis.

Authors:  J A Forrest; D J Shearman
Journal:  Am J Dig Dis       Date:  1975-05

2.  FACTORS AFFECTING REGIONAL DISTRIBUTION OF VENTILATION AND PERFUSION IN THE LUNG.

Authors:  A C BRYAN; L G BENTIVOGLIO; F BEEREL; H MACLEISH; A ZIDULKA; D V BATES
Journal:  J Appl Physiol       Date:  1964-05       Impact factor: 3.531

3.  Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis.

Authors:  J Lieberman
Journal:  Am J Med       Date:  1975-09       Impact factor: 4.965

4.  Sulphasalazine induced lung disease.

Authors:  G R Jones; D N Malone
Journal:  Thorax       Date:  1972-11       Impact factor: 9.139

5.  Ulcerative colitis, colitic spondylitis and associated apical pulmonary fibrosis.

Authors:  J Meadway
Journal:  Proc R Soc Med       Date:  1974-05

6.  Respiratory disease due to sulphasalazine.

Authors:  P Thomas; A Seaton; J Edwards
Journal:  Clin Allergy       Date:  1974-03

7.  The epidemiologic and demographic characteristics of inflammatory bowel disease: an analysis of a computerized file of 1400 patients.

Authors:  B H Rogers; L M Clark; J B Kirsner
Journal:  J Chronic Dis       Date:  1971-12

8.  Pulmonary vasculitis--an uncommon complication of ulcerative colitis. Report of a case.

Authors:  J I Isenberg; H Goldstein; A R Korn; R S Ozeran; V Rosen
Journal:  N Engl J Med       Date:  1968-12-19       Impact factor: 91.245

9.  Unexplained bronchopulmonary disease with inflammatory bowel disease.

Authors:  S C Kraft; R H Earle; M Roesler; J R Esterly
Journal:  Arch Intern Med       Date:  1976-04

10.  Fibrosing alveolitis and treatment with sulphasalazine.

Authors:  D Davies; A MacFarlane
Journal:  Gut       Date:  1974-03       Impact factor: 23.059

View more
  30 in total

Review 1.  Symptomatic gastrointestinal sarcoidosis: case report and review of the literature.

Authors:  Ripudaman S Beniwal; Oscar W Cummings; Won Kyoo Cho
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

2.  Crohn's disease of the lung.

Authors:  J W Puntis; M J Tarlow; F Raafat; I W Booth
Journal:  Arch Dis Child       Date:  1990-11       Impact factor: 3.791

3.  Crohn's disease.

Authors:  S Murch; J A Walker-Smith
Journal:  Arch Dis Child       Date:  1991-04       Impact factor: 3.791

4.  Alimentary tract granulomas.

Authors:  D G James; R E Pounder
Journal:  Postgrad Med J       Date:  1991-05       Impact factor: 2.401

5.  Mycobacterium avium subsp. paratuberculosis in the catchment area and water of the River Taff in South Wales, United Kingdom, and its potential relationship to clustering of Crohn's disease cases in the city of Cardiff.

Authors:  R W Pickup; G Rhodes; S Arnott; K Sidi-Boumedine; T J Bull; A Weightman; M Hurley; J Hermon-Taylor
Journal:  Appl Environ Microbiol       Date:  2005-04       Impact factor: 4.792

6.  Toxic oxygen metabolite production by circulating phagocytic cells in inflammatory bowel disease.

Authors:  J G Williams; L E Hughes; M B Hallett
Journal:  Gut       Date:  1990-02       Impact factor: 23.059

7.  Immunological study of histologically non-involved jejunum during Crohn's disease: evidence for reduced in vivo secretion of secretory IgA.

Authors:  P Marteau; J F Colombel; J Nemeth; J P Vaerman; J C Dive; J C Rambaud
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

Review 8.  [Bronchopulmonary manifestations of gastroenterologic and hepatic diseases].

Authors:  A Tromm; G H Micklefield; D Hüppe
Journal:  Med Klin (Munich)       Date:  1997-12-15

9.  Airway function and markers of airway inflammation in patients with treated hypothyroidism.

Authors:  S S Birring; R B Patel; D Parker; S McKenna; B Hargadon; W R Monteiro; J F Falconer Smith; I D Pavord
Journal:  Thorax       Date:  2005-03       Impact factor: 9.139

Review 10.  Pulmonary involvement and allergic disorders in inflammatory bowel disease.

Authors:  Nikolaos E Tzanakis; Ioanna G Tsiligianni; Nikolaos M Siafakas
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.